RE: Nordic Nanovector to present at 3rd Targeted ...
finansavisen.no › forum › threadJul 12, 2021 · Oslo, Norway, 7 December 2021. Nordic Nanovector ASA (OSE: NANOV), a clinical-stage biotech company focused on CD37-targeted therapies for haematological cancers and immune diseases announces that its Chief Scientific Officer, Jostein Dahle, will give a presentation on 8 December at the 3rd Targeted Radiopharmaceutical Summit 2021 event (7-9 ...
Finansavisen | fa.no
finansavisen.noHver dag gir Finansavisen deg nyheter og Trygve Hegnars leder og gode råd. Stor lørdagsavis hver helg! Ingen norsk avis dekker børsnyheter som oss.